Novo Nordisk offers reduced path wireway via direct consumer pharmacy
Novo Nordisis’s Weil -Weighing Loss Medicine has a meteoric increase in popularity.
Nurphoto | Getty pictures
Novo Nordisk On Wednesday, it will offer its weight loss medication for less than half of its usual price per month via a new online pharmacy from Direct-to-Consumer.
The number of cash The offer is available to millions of patients without insurance coverage for the blockbuster injection. The aim is to make more people available and at the same time ensure that the patients use the brand medication instead of cheaper, compiled imitators that became more and more popular during a recently dissolved US deficiency in Novo Nordisk’s medication.
The pharmacy called Novocare enables the patient to pay 499 US dollars in cash per month for the weekly medication. Wegovy’s list price before insurance and other discounts is almost $ 1,350 per month.
The site can also send Wortovy recipes directly to the patients’ houses via a special practice partner. Among other things, Novocare also offers refill memories and access to live support from a company manager of the company, including.
“Patients and prescribers have a different option that offers a convenient access to all cans of real, approved path approved by the FDA at a lower cost in our high-quality pen,” said Dave Moore, Executive Vice President of US operations and global business development.
In particular, the company said in the “near future” that the new savings offer for Wegven to use cash paid patients who use traditional retail pharmacies will expand so that they can also pay a cheaper price.
The step of the Danish drug broker follows a similar strategy of his main competitor Eli Lilly. The two companies are fighting to dominate the so-called GLP-1S market, which mimic certain intestinal hormones to suppress the appetite and regulate blood sugar.
More CNBC health insurance
In January 2024, Eli Lilly launched her own online pharmacy from Direct-to Consumer, Lillydirect, to help patients access his weight loss drug Zepbound.
The website enables justified patients to receive a prescription through a telemedicine provider and can be delivered at home. Lillydirect has also offered Zepbound in single dose vials, which is half or even less than the usual monthly list price of $ 1,000.
In the past few months, the Food and Drug Administration has explained the US lack of Zepbound and the pathway about the US deficiency. This decision prevents certain connecting pharmacies from creating non -approved versions of the injections.
Novocare helps patients “to avoid the considerable risks that can be equipped by the compounding market, as warned by respected organizations, experts in the medical community and the FDA,” said Novo Nordisk in a statement.
